newsfilter
← Latest News
Business Wire·

Aimmune Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference

BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that its Chief Financial Officer, Eric Bjerkholt, will present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020 at 2:50 p.m. E.T.